Wells Fargo & Co reaffirmed an "outperform" rating and set a $160.00 price objective (up previously from $155.00) on shares of Johnson & Johnson in a research report on Friday. The company has market cap of $3.51 billion. The stock increased 2.51% or $1.45 during the last trading session, reaching $59.33. Zacks' earnings per share calculations are an average based on a survey of sell-side research analysts that that provide coverage for Johnson & Johnson. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 13, 2017 and is uptrending. It has outperformed by 5.34% the S&P500.
Dubuque Bank & Trust Company increased Johnson & Johnson (JNJ) stake by 42.09% reported in 2017Q3 SEC filing. Lenox Wealth Advisors Inc. now owns 876 shares of the company's stock worth $116,000 after buying an additional 5 shares in the last quarter. The Sumitomo Life Insurance Company holds 108,212 shares with $14.07 million value, up from 104,840 last quarter. Beech Hill Advisors Inc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $391.59B market cap company. The stock increased 0.78% or $1.125 during the last trading session, reaching $145.915. Based on a recent trade, the shares are 0.33% away from the 52-week high and 31.97% from the 52-week low. Mason Street Advsr Limited stated it has 1.19% in Johnson & Johnson (NYSE:JNJ). It has underperformed by 4.16% the S&P500.
Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It has no change, as 45 investors sold Johnson & Johnson shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. Court Place Advisors Limited Liability Corp reported 6,702 shares. Moreover, Tnb Fincl has 0.7% invested in Johnson & Johnson (NYSE:JNJ) for 32,588 shares. Intrust Commercial Bank Na holds 7,305 shares or 0.28% of its portfolio. It also reduced Chubb Limited Com stake by 3,966 shares and now owns 21,894 shares. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 12, 2017 and is uptrending. Greylin Inv Mangement invested 3.8% in Johnson & Johnson (NYSE:JNJ). The fund owned 161,650 shares of the company's stock after selling 1,945 shares during the quarter. Cullinan Assocs Inc reported 134,693 shares or 1.35% of all its holdings. Premier Asset Management LLC lifted its position in shares of Johnson & Johnson by 0.4% in the second quarter. Asset Inc owns 182,265 shares for 0.4% of their portfolio. Lynch & Associates IN now owns 93,710 shares of the company's stock worth $12,397,000 after buying an additional 841 shares during the last quarter. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47 % negative EPS growth. Piper Jaffray maintained the shares of JNJ in report on Monday, October 2 with "Hold" rating. Compass Capital Mngmt holds 0.1% or 5,248 shares. Ledyard National Bank reported 1.13% in Johnson & Johnson (NYSE:JNJ). Provise Management Group Llc sold 4,385 shares as Johnson & Johnson (JNJ)'s stock rose 6.85%. Therefore 65% are positive. JNJ was included in 84 notes of analysts from August 7, 2015.
Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. The stock has "Hold" rating by Stifel Nicolaus on Tuesday, July 18. JP Morgan maintained Babcock International Group plc (LON:BAB) rating on Tuesday, April 5. The company was maintained on Tuesday, July 18 by BMO Capital Markets. Barclays Capital maintained Johnson & Johnson (NYSE:JNJ) on Wednesday, October 18 with "Equal-Weight" rating.
Bancorpsouth Inc, which manages about $1.01B US Long portfolio, upped its stake in Exxon Mobil Corp (NYSE:XOM) by 4,384 shares to 83,372 shares, valued at $6.84 million in 2017Q3, according to the filing.More news: Zainab murder: New CCTV footage surfaces
More news: Flores snubs Stoke job to remain at Espanyol
More news: Trump to approve Iran nuclear deal for last time
Nj State Employees Deferred Compensation Plan, which manages about $551.67 million US Long portfolio, upped its stake in Uniti Group Inc by 30,000 shares to 55,169 shares, valued at $809,000 in 2017Q3, according to the filing. It also increased its holding in Schwab Strategic Tr (SCHH) by 44,468 shares in the quarter, for a total of 64,128 shares, and has risen its stake in Schwab Strategic Tr (SCHA).
Since August 4, 2017, it had 0 insider buys, and 3 insider sales for $513.86 million activity. Parsec Financial Management Inc.'s holdings in Johnson & Johnson were worth $22,623,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Analysts await Chevron Corporation (NYSE:CVX) to report earnings on January, 26. They expect $1.72 earnings per share, up 8.86% or $0.14 from last year's $1.58 per share. JNJ's profit would be $4.62 billion giving it 21.19 P/E if the $1.72 EPS is correct. The company's revenue was up 10.3% compared to the same quarter last year. equities research analysts anticipate that Johnson & Johnson will post 7.28 earnings per share for the current year.
Among 10 analysts covering Woodward Governor (NASDAQ:WWD), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 67% are positive. Woodward Governor had 27 analyst reports since July 21, 2015 according to SRatingsIntel. Biegelsen covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Merit Medical Systems. (NASDAQ:WWD) earned "Hold" rating by Jefferies on Monday, July 24. The firm has "Buy" rating given on Wednesday, October 18 by Argus Research. On Thursday, January 26 the stock rating was downgraded by Wells Fargo to "Market Perform". (NYSE:NRZ) rating on Thursday, October 6. The firm earned "Buy" rating on Friday, September 22 by RBC Capital Markets. The firm has "Hold" rating by Citigroup given on Monday, September 25. The rating was maintained by Cowen & Co on Monday, July 17 with "Hold".